Corteva
Market Cap
US$20.3b
Last Updated
2020/07/07 23:51 UTC
Data Sources
Company Financials +
Executive Summary
Corteva, Inc. operates in the agriculture business.
Rewards
Risk Analysis
Snowflake Analysis
Excellent balance sheet and fair value.
Similar Companies
Share Price & News
How has Corteva's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: CTVA has not had significant price volatility in the past 3 months.
Market Performance
7 Day Return
1.3%
CTVA
3.2%
US Chemicals
1.7%
US Market
1 Year Return
0.6%
CTVA
-2.4%
US Chemicals
6.0%
US Market
Return vs Industry: CTVA exceeded the US Chemicals industry which returned -3.3% over the past year.
Return vs Market: CTVA underperformed the US Market which returned 7.4% over the past year.
Shareholder returns
| CTVA | Industry | Market | |
|---|---|---|---|
| 7 Day | 1.3% | 3.2% | 1.7% |
| 30 Day | -11.5% | -4.0% | -0.5% |
| 90 Day | 4.2% | 19.8% | 17.8% |
| 1 Year | 2.6%0.6% | -0.1%-2.4% | 8.2%6.0% |
| 3 Year | n/a | 16.4%-5.4% | 36.3%27.4% |
| 5 Year | n/a | 34.3%4.0% | 63.0%45.0% |
Price Volatility Vs. Market
How volatile is Corteva's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 months ago | Simply Wall St
Does Corteva, Inc. (NYSE:CTVA) Have A Place In Your Dividend Stock Portfolio?3 months ago | Simply Wall St
We Think Corteva (NYSE:CTVA) Is Taking Some Risk With Its Debt4 months ago | Simply Wall St
How Many Corteva, Inc. (NYSE:CTVA) Shares Do Institutions Own?Valuation
Is Corteva undervalued compared to its fair value and its price relative to the market?
46.2%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: CTVA ($27.14) is trading below our estimate of fair value ($50.42)
Significantly Below Fair Value: CTVA is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: CTVA is poor value based on its PE Ratio (113.7x) compared to the Chemicals industry average (21x).
PE vs Market: CTVA is poor value based on its PE Ratio (113.7x) compared to the US market (16.5x).
Price to Earnings Growth Ratio
PEG Ratio: CTVA is poor value based on its PEG Ratio (4x)
Price to Book Ratio
PB vs Industry: CTVA is good value based on its PB Ratio (0.9x) compared to the US Chemicals industry average (2x).
Next Steps
Future Growth
How is Corteva forecast to perform in the next 1 to 3 years based on estimates from 20 analysts?
28.5%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CTVA's forecast earnings growth (28.5% per year) is above the savings rate (2.2%).
Earnings vs Market: CTVA's earnings (28.5% per year) are forecast to grow faster than the US market (22.8% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: CTVA's revenue (3.5% per year) is forecast to grow slower than the US market (9.3% per year).
High Growth Revenue: CTVA's revenue (3.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CTVA's Return on Equity is forecast to be low in 3 years time (6.4%).
Next Steps
Past Performance
How has Corteva performed over the past 5 years?
-37.6%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CTVA has a large one-off loss of $845.0M impacting its March 31 2020 financial results.
Growing Profit Margin: CTVA became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: CTVA has become profitable over the past 5 years, growing earnings by -37.6% per year.
Accelerating Growth: CTVA has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: CTVA has become profitable in the last year, making it difficult to compare its past year earnings growth to the Chemicals industry (-11.3%).
Return on Equity
High ROE: CTVA's Return on Equity (0.8%) is considered low.
Next Steps
Financial Health
How is Corteva's financial position?
Financial Position Analysis
Short Term Liabilities: CTVA's short term assets ($14.7B) exceed its short term liabilities ($9.2B).
Long Term Liabilities: CTVA's short term assets ($14.7B) exceed its long term liabilities ($9.7B).
Debt to Equity History and Analysis
Debt Level: CTVA's debt to equity ratio (9%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if CTVA's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: CTVA's debt is well covered by operating cash flow (31.3%).
Interest Coverage: CTVA's interest payments on its debt are well covered by EBIT (50.7x coverage).
Balance Sheet
Next Steps
Dividend
What is Corteva current dividend yield, its reliability and sustainability?
1.92%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: CTVA's dividend (1.92%) is higher than the bottom 25% of dividend payers in the US market (1.66%).
High Dividend: CTVA's dividend (1.92%) is low compared to the top 25% of dividend payers in the US market (4.49%).
Stability and Growth of Payments
Stable Dividend: Too early to tell whether CTVA's dividend payments have been stable as they only just started paying a dividend.
Growing Dividend: Too early to tell if CTVA's dividend payments are increasing as they only just started paying a dividend.
Current Payout to Shareholders
Dividend Coverage: With its high payout ratio (217.8%), CTVA's dividend payments are not well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: CTVA's dividends in 3 years are forecast to be well covered by earnings (27.2% payout ratio).
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
1.1yrs
Average board tenure
CEO
Jim Collins (57yo)
no data
Tenure
US$11,357,053
Compensation
Mr. James C. Collins, Jr., also known as Jim, is the Chief Executive Officer of Corteva, Inc. and has been its Director since May 6, 2019. Mr. Collins has been an Executive Vice President of Agriculture Bu ...
CEO Compensation Analysis
Compensation vs Market: Jim's total compensation ($USD11.36M) is about average for companies of similar size in the US market ($USD11.50M).
Compensation vs Earnings: Jim's compensation has been consistent with company performance over the past year.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | no data | US$11.36m | 0.015% $3.0m | |
| Independent Director | 1.08yrs | US$367.53k | 0.0069% $1.4m | |
| Independent Director | 1.08yrs | US$237.58k | 0.0035% $712.9k | |
| Independent Chairman of the Board | no data | US$424.15k | 0.0040% $820.6k | |
| Independent Director | 1.08yrs | US$252.16k | 0.0028% $568.7k | |
| Independent Director | 1.08yrs | US$237.46k | 0.0025% $499.6k | |
| Independent Director | 1.08yrs | US$362.04k | 0.000010% $2.0k | |
| Independent Director | 1.08yrs | US$237.46k | 0.000010% $2.0k | |
| Independent Director | 1.08yrs | US$258.00k | no data | |
| Independent Director | 1.08yrs | US$237.58k | no data |
1.1yrs
Average Tenure
68.5yo
Average Age
Experienced Board: CTVA's board of directors are not considered experienced ( 1.1 years average tenure), which suggests a new board.
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: CTVA insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Corteva, Inc.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: Corteva, Inc.
- Ticker: CTVA
- Exchange: NYSE
- Founded:
- Industry: Fertilizers and Agricultural Chemicals
- Sector: Materials
- Market Cap: US$20.311b
- Shares outstanding: 748.37m
- Website: https://www.corteva.com
Number of Employees
Location
- Corteva, Inc.
- 974 Centre Road
- Wilmington
- Delaware
- 19805
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| CTVA | NYSE (New York Stock Exchange) | Yes | Common Stock | US | USD | Jun 2019 |
| 2X0 | BST (Boerse-Stuttgart) | Yes | Common Stock | DE | EUR | Jun 2019 |
| CTVA * | BMV (Bolsa Mexicana de Valores) | Yes | Common Stock | MX | MXN | Jun 2019 |
| 0A1W | LSE (London Stock Exchange) | Yes | Common Stock | GB | EUR | Jun 2019 |
| 2X0 | DB (Deutsche Boerse AG) | Yes | Common Stock | DE | EUR | Jun 2019 |
| CTVA | WBAG (Wiener Boerse AG) | Yes | Common Stock | AT | EUR | Jun 2019 |
Biography
Corteva, Inc. operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and disease, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, below-ground nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. is headquartered in Wilmington, Delaware.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2020/07/07 23:51 |
| End of Day Share Price | 2020/07/07 00:00 |
| Earnings | 2020/03/31 |
| Annual Earnings | 2019/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.